We are live on ! Find out more
ZJYL

Jin Medical International

Delisted

ZJYL was delisted on the 31st of July, 2026.

10 hedge funds and large institutions have $88.6K invested in Jin Medical International in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

11% more funds holding

Funds holding: 910 (+1)

0.01% more ownership

Funds ownership: 0.01%0.01% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

32% less capital invested

Capital invested by funds: $130K → $88.6K (-$40.9K)

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$25.9K +$34.7K +5,890 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$23.4K
Jane Street
3
Jane Street
New York
$11.2K +$15K +2,546 New
Renaissance Technologies
4
Renaissance Technologies
New York
$8.8K +$11.8K +2,000 New
Osaic Holdings
5
Osaic Holdings
Arizona
$7.04K +$2.65K +450 +39%
XT
6
XTX Topco
Cayman Islands
$6.3K +$3.2K +543 +61%
TSS
7
Two Sigma Securities
New York
$4.83K +$6.47K +1,099 New
UBS Group
8
UBS Group
Switzerland
$987 -$11K -1,860 -89%
BIA
9
Bell Investment Advisors
California
$34
Morgan Stanley
10
Morgan Stanley
New York
$22 -$29 -5 -50%
Millennium Management
11
Millennium Management
New York
-$11.1K -979 Closed
HF
12
HRT Financial
New York
-$8K -774 Closed
TRCT
13
Tower Research Capital (TRC)
New York
-$56 -5 Closed

ZJYL Hedge Fund Activity: Q4 2025 in Review

10 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q4 2025, worth a combined $88.6K — down 32% from $130K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ZJYL positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $34.7K. The largest seller was Millennium Management, exiting entirely with an estimated $11.1K sold.

  • 10 institutional investors held Jin Medical International (ZJYL) as of Q4 2025, up from 9 in Q3 2025.
  • Funds reported $88.6K of Jin Medical International stock for Q4 2025, down 32% quarter-over-quarter.
  • 4 funds opened new Jin Medical International positions in Q4 2025 and 3 closed out, a net change of +1 holder.
  • The largest Jin Medical International buyer in Q4 2025 was Citadel Advisors, an estimated $34.7K added.
  • The largest Jin Medical International seller in Q4 2025 was Millennium Management, an estimated $11.1K sold.

Based on aggregated 13F filings for Q4 2025.